A systematic review for pursuing the presence of antibiotic associated enterocolitis caused by methicillin resistant

Kentaro Iwata1, Asako Doi, Takahiko Fukuchi

  • 1Division of Infectious Disease, Kobe University Hospital, 7-5-2 Kusunokicho, Chuoku, 650-0017 Kobe, Hyogo, Japan. kiwata@med.kobe-u.ac.jp.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) likely causes antibiotic-associated enterocolitis (AAE), though less frequently than previously suggested. This systematic review confirmed MRSA

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Gastroenterology

Background:

  • The role of methicillin-resistant Staphylococcus aureus (MRSA) in antibiotic-associated enterocolitis (AAE) pathogenesis is unclear.
  • Previous studies have yielded inconclusive results regarding MRSA's causative role in AAE.
  • Many Japanese case reports on MRSA-induced AAE lacked scientific rigor and were overlooked.

Purpose of the Study:

  • To systematically review literature and verify the existence of AAE caused by MRSA.
  • To apply established criteria to assess MRSA's etiological role in AAE.

Main Methods:

  • Conducted a systematic literature review using MEDLINE/PubMed, EMBASE, Cochrane, and Japan Medical Abstract Society databases.
  • Searched for studies published before March 2013.
  • Utilized 9 criteria, adapted from Klebsiella oxytoca AAE studies, to evaluate MRSA's role.

Main Results:

  • Evaluated 1,999 articles, with 45 case reports/series and 9 basic studies reviewed in detail.
  • Identified studies with pathological and microscopic evidence supporting MRSA as an etiological agent.
  • Confirmed MRSA's role by collectively analyzing multiple studies to fulfill all 9 criteria, including comparative studies, toxin detection, and animal models.

Conclusions:

  • Antibiotic-associated enterocolitis caused by MRSA likely exists.
  • The incidence of MRSA-induced AAE may be rarer than suggested by prior Japanese literature.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
215
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
138
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
88